Literature DB >> 22974139

Design and rationale of the Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy (MR RESCUE) Trial.

Chelsea S Kidwell1, Reza Jahan, Jeffry R Alger, Timothy J Schaewe, Judy Guzy, Sidney Starkman, Robert Elashoff, Jeffrey Gornbein, Val Nenov, Jeffrey L Saver.   

Abstract

RATIONALE: Multimodal imaging has the potential to identify acute ischaemic stroke patients most likely to benefit from late recanalization therapies. AIMS: The general aim of the Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy Trial is to investigate whether multimodal imaging can identify patients who will benefit substantially from mechanical embolectomy for the treatment of acute ischaemic stroke up to eight-hours from symptom onset.
DESIGN: Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy is a randomized, controlled, blinded-outcome clinical trial. POPULATION STUDIED: Acute ischaemic stroke patients with large vessel intracranial internal carotid artery or middle cerebral artery M1 or M2 occlusion enrolled within eight-hours of symptom onset are eligible. The study sample size is 120 patients. STUDY INTERVENTION: Patients are randomized to endovascular embolectomy employing the Merci Retriever (Concentric Medical, Mountain View, CA) or the Penumbra System (Penumbra, Alameda, CA) vs. standard medical care, with randomization stratified by penumbral pattern. OUTCOMES: The primary aim of the trial is to test the hypothesis that the presence of substantial ischaemic penumbral tissue visualized on multimodal imaging (magnetic resonance imaging or computed tomography) predicts patients most likely to respond to mechanical embolectomy for treatment of acute ischaemic stroke due to a large vessel, intracranial occlusion up to eight-hours from symptom onset. This hypothesis will be tested by analysing whether pretreatment imaging pattern has a significant interaction with treatment as a determinant of functional outcome based on the distribution of scores on the modified Rankin Scale measure of global disability assessed 90 days post-stroke. Nested hypotheses test for (1) treatment efficacy in patients with a penumbral pattern pretreatment, and (2) absence of treatment benefit (equivalency) in patients without a penumbral pattern pretreatment. An additional aim will only be tested if the primary hypothesis of an interaction is negative: that patients treated with mechanical embolectomy have improved functional outcome vs. standard medical management.
© 2012 The Authors. International Journal of Stroke © 2012 World Stroke Organization.

Entities:  

Keywords:  MRI; clinical trial; embolectomy; ischaemic stroke; neuroimaging; penumbra

Mesh:

Year:  2012        PMID: 22974139      PMCID: PMC3525782          DOI: 10.1111/j.1747-4949.2012.00894.x

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  22 in total

1.  Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association.

Authors:  Harold P Adams; Robert J Adams; Thomas Brott; Gregory J del Zoppo; Anthony Furlan; Larry B Goldstein; Robert L Grubb; Randall Higashida; Chelsea Kidwell; Thomas G Kwiatkowski; John R Marler; George J Hademenos
Journal:  Stroke       Date:  2003-04       Impact factor: 7.914

2.  Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years.

Authors:  Opeolu Adeoye; Richard Hornung; Pooja Khatri; Dawn Kleindorfer
Journal:  Stroke       Date:  2011-06-02       Impact factor: 7.914

3.  Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial.

Authors:  Wade S Smith; Gene Sung; Sidney Starkman; Jeffrey L Saver; Chelsea S Kidwell; Y Pierre Gobin; Helmi L Lutsep; Gary M Nesbit; Thomas Grobelny; Marilyn M Rymer; Isaac E Silverman; Randall T Higashida; Ronald F Budzik; Michael P Marks
Journal:  Stroke       Date:  2005-06-16       Impact factor: 7.914

4.  Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial.

Authors:  B C Tilley; J Marler; N L Geller; M Lu; J Legler; T Brott; P Lyden; J Grotta
Journal:  Stroke       Date:  1996-11       Impact factor: 7.914

5.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

Authors: 
Journal:  N Engl J Med       Date:  1985-04-04       Impact factor: 91.245

Review 6.  Characterizing the target of acute stroke therapy.

Authors:  M Fisher
Journal:  Stroke       Date:  1997-04       Impact factor: 7.914

7.  Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI.

Authors:  P A Barber; D G Darby; P M Desmond; Q Yang; R P Gerraty; D Jolley; G A Donnan; B M Tress; S M Davis
Journal:  Neurology       Date:  1998-08       Impact factor: 9.910

8.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

9.  Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

Authors:  Werner Hacke; Geoffrey Donnan; Cesare Fieschi; Markku Kaste; Rüdiger von Kummer; Joseph P Broderick; Thomas Brott; Michael Frankel; James C Grotta; E Clarke Haley; Thomas Kwiatkowski; Steven R Levine; Chris Lewandowski; Mei Lu; Patrick Lyden; John R Marler; Suresh Patel; Barbara C Tilley; Gregory Albers; Erich Bluhmki; Manfred Wilhelm; Scott Hamilton
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

10.  Utilization of intravenous tissue plasminogen activator for acute ischemic stroke.

Authors:  Irene L Katzan; Maxim D Hammer; Eric D Hixson; Anthony J Furlan; Alex Abou-Chebl; Deborah M Nadzam
Journal:  Arch Neurol       Date:  2004-03
View more
  22 in total

Review 1.  Neuroimaging of cerebral ischemia and infarction.

Authors:  Carlos Leiva-Salinas; Max Wintermark; Chelsea S Kidwell
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

2.  Critical early thrombolytic and endovascular reperfusion therapy for acute ischemic stroke victims: a call for adjunct neuroprotection.

Authors:  Paul A Lapchak
Journal:  Transl Stroke Res       Date:  2015-08-29       Impact factor: 6.829

Review 3.  Developing practice recommendations for endovascular revascularization for acute ischemic stroke.

Authors:  Marc A Lazzaro; Roberta L Novakovic; Andrei V Alexandrov; Ziad Darkhabani; Randall C Edgell; Joey English; Donald Frei; Dara G Jamieson; Vallabh Janardhan; Nazli Janjua; Rashid M Janjua; Irene Katzan; Pooja Khatri; Jawad F Kirmani; David S Liebeskind; Italo Linfante; Thanh N Nguyen; Jeffrey L Saver; Lori Shutter; Andrew Xavier; Dileep Yavagal; Osama O Zaidat
Journal:  Neurology       Date:  2012-09-25       Impact factor: 9.910

Review 4.  How to make better use of thrombolytic therapy in acute ischemic stroke.

Authors:  Geoffrey A Donnan; Stephen M Davis; Mark W Parsons; Henry Ma; Helen M Dewey; David W Howells
Journal:  Nat Rev Neurol       Date:  2011-06-14       Impact factor: 42.937

5.  Safety of high doses of urokinase and reteplase for acute ischemic stroke.

Authors:  V Misra; R El Khoury; R Arora; P R Chen; S Suzuki; N Harun; N R Gonzales; A D Barreto; J C Grotta; S I Savitz
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-24       Impact factor: 3.825

Review 6.  Current status of endovascular stroke treatment.

Authors:  Philip M Meyers; H Christian Schumacher; E Sander Connolly; Eric J Heyer; William A Gray; Randall T Higashida
Journal:  Circulation       Date:  2011-06-07       Impact factor: 29.690

Review 7.  Imaging stroke patients with unclear onset times.

Authors:  Ona Wu; Lee H Schwamm; A Gregory Sorensen
Journal:  Neuroimaging Clin N Am       Date:  2011-05       Impact factor: 2.264

8.  Multiparametric MRI and CT models of infarct core and favorable penumbral imaging patterns in acute ischemic stroke.

Authors:  Chelsea S Kidwell; Max Wintermark; Deidre A De Silva; Timothy J Schaewe; Reza Jahan; Sidney Starkman; Tudor Jovin; Jason Hom; Mouhammad Jumaa; Jeffrie Schreier; Jeffrey Gornbein; David S Liebeskind; Jeffry R Alger; Jeffrey L Saver
Journal:  Stroke       Date:  2012-12-11       Impact factor: 7.914

Review 9.  Clinical trial design for endovascular ischemic stroke intervention.

Authors:  Osama O Zaidat; David S Liebeskind; Randall C Edgell; Catherine M Amlie-Lefond; Junaid S Kalia; Andrei V Alexandrov
Journal:  Neurology       Date:  2012-09-25       Impact factor: 9.910

10.  Relative filling time delay based on CT perfusion source imaging: a simple method to predict outcome in acute ischemic stroke.

Authors:  W Cao; B C V Campbell; Q Dong; S M Davis; B Yan
Journal:  AJNR Am J Neuroradiol       Date:  2014-04-17       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.